相关实验视频

Updated: Jul 2, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

18.8K

基于DNA复制应激特征的TNBC中新辅助化疗反应预测和治疗灵敏性的组合模型

Meishun Hu1, Qifan Luo1, Jun Li1

  • 1Department of Thyroid Breast Surgery, Zhongnan Hospital of Wuhan University, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Wuhan, 430071, Hubei, People's Republic of China.

Scientific reports
|October 31, 2025
PubMed
概括

这项研究确定了八个关键基因,并开发了一种整体模型来预测三阴性乳腺癌 (TNBC) 治疗有效性,强调DNA复制应激 (DRS) 对于个性化治疗至关重要.

关键词:
DNA复制的压力是DNA复制的压力.机器学习 机器学习新辅助化学疗法新辅助化学疗法美国TNBC电视台

更多相关视频

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

6.9K
Quantifying Replication Stress in Ovarian Cancer Cells Using Single-Stranded DNA Immunofluorescence06:25

Quantifying Replication Stress in Ovarian Cancer Cells Using Single-Stranded DNA Immunofluorescence

Published on: February 10, 2023

2.4K

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...